Free Sample Reports

222 Results (Page 2 of 19)

All Free Sample Market Research Reports

Pharmaceuticals

Middle East Neurology Drugs Market Analysis Sample Report

This report presents a strategic analysis of the Middle East Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Middle East Neurology Drugs Market, offering unmatched value, accuracy and expert insights.

LAST UPDATED: Mar, 2024

Healthcare Services

Malaysia Healthcare Insurance Market Analysis Sample Report

The Malaysia healthcare insurance market is projected to grow from $3.26 Bn in 2022 to $5.94 Bn by 2030, registering a CAGR of 7.8% during the forecast period of 2022-2030. The main factors driving the growth would be increasing healthcare costs, government initiatives, a rise in medical tourism and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Tune Protect, Etiqa Insurance, Hong Leong Assurance, Great Eastern Life Assurance and Generali.

LAST UPDATED: Mar, 2024

Healthcare Services

Kenya Dental Care Market Analysis Sample Report

Kenya's Dental Care Market is valued at around $xx Mn in 2022 and is expected to reach $xx Mn by 2030, growing at a CAGR of xx% during the forecast period. Dental caries are common in Kenya, with 63% of 12-year-olds experiencing dental caries in their permanent teeth. Paediatric dentistry is a rapidly growing trend in Kenya for meeting dental needs. Dental Spa, DentalCare, and Nairobi Dental & Orthodontics are the market leaders. This report by Insights10 is segmented by treatment type, age group, and by clinical setup, and demography.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Japan Retail Pharmacy Market Analysis Sample Report

Japan's Retail pharmacy market is projected to grow from $64.56 Bn in 2022 to $114.28 Bn by 2030, registering a CAGR of 7.4% during the forecast period of 2022-2030. The growing demand for convenience in healthcare is driving the retail pharmacy market as more people are looking for ways to easily access and manage their medications. The retail pharmacy market in Japan is highly competitive, with several large players dominating the market, including Matsumoto Kiyoshi Holdings Co., Ltd, Aeon Co., Ltd, and Lawson, Inc.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Hong Kong Sleep Disorders Market Analysis Sample Report

This report presents a strategic analysis of the Hong Kong Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Hong Kong Sleep Disorders Market, offering unmatched value, accuracy and expert insights.

LAST UPDATED: Mar, 2024

Clinical Trials

Global Clinical Trial Patient Recruitment Service Market Analysis Sample Report

The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Bn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. Some key players in the global clinical trial patient recruitment services market include IQVIA, Parexel International, PRA Health Sciences, Syneos Health, and WCG Clinical. Other important players include ICON plc, Medpace, Charles River Laboratories, and Premier Research.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Germany ADHD Therapeutics Market Analysis Sample Report

Germany's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $1.08 Bn in 2022 to $1.68 Bn in 2030 with a CAGR of 5.7% for the year 2022-30. The major market drivers include rising awareness of the disorder and the increasing supply of ADHD drugs which include both stimulants and non-stimulants. The Germany ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the major competitors in the market are Adragos Pharma, Hermes Arzneimittel, and Shire.

LAST UPDATED: Mar, 2024

OTC & Nutraceuticals

Europe Over The Counter (OTC) Market Analysis Sample Report

Europe's over-the-counter (OTC) pharmaceuticals market size was valued at $26125 Mn in 2022 and is estimated to expand at a CAGR of 4.28% from 2022 to 2030 and will reach $36531.2 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.

LAST UPDATED: Mar, 2024

Healthcare Services

Canada Physiotherapy Market Analysis Sample Report

Canada's physiotherapy market size was valued at $4.25 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.85% from 2022 to 2030 and will reach $6.70 Bn in 2030. The Canada physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions including diabetes and obesity as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the Canada physiotherapy market are BTL Industries, Performance Health, ITO Co., Ltd., Enraf-Nonius B.V., and others.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Canada Biosimilars Market Analysis Sample Report

Canada's biosimilar market size was valued at $1.53 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 22.2% from 2022 to 2030 and will reach $7.63 Bn in 2030. The market is segmented by product type and indication type. This market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Brazil Orphan Disease Drugs Market Analysis Sample Report

Brazil's Orphan Diseases Drugs Market is projected to grow from $3.870 Bn in 2022 to $9.114 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022-2030. In Brazil, there is a significant population affected by rare diseases, with estimates suggesting that around 8 Mn Brazilians suffer from one of the more than 7,000 rare diseases currently known. The most common types of rare diseases in Brazil include genetic disorders, neurological conditions, and blood disorders. The key players in the Brazil orphan diseases drugs market include Pfizer, Roche Holding, Sanofi, Novartis International, Merck, and Amgen.

LAST UPDATED: Mar, 2024

OTC & Nutraceuticals

Brazil Nutritional Supplements Market Analysis Sample Report

By 2030, it is anticipated that the Brazil Nutrition and Supplements market will reach a value of $19.71 Bn from $9.54 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Herbarium, Biofield, and Bioenergy. The market for nutrition and supplements in Brazil is primarily driven by government initiatives, increasing consumer awareness for health and lifestyle and sports nutrition supplements. The Brazil nutrition and supplements market in Brazil is segmented by Type, Product, application, and Distribution Channel.

LAST UPDATED: Mar, 2024

subscribe to our newsletter
up